On Jun 11, HEWSON MARILLYN A, Director bought 3,000 shares of Johnson & Johnson (NYSE: JNJ), with the average selling price of the stock being $139.68 per share. The total amount realized from this purchase $419,040. A document was filed with the Securities and Exchange Commission to notify the public about the purchase of the shares.
In addition to that, Vice Chair, Exec Committee – Stoffels Paulus exercised an option an extra 31,428 shares of this stock in a transaction that took place a day before, on Feb 11, with a share exercised an option at an average of $0.00 and a total of $0 was realized from this transaction. After the transaction, the Vice Chair, Exec Committee – Stoffels Paulus was left with 242,246 shares of the company’s stock, which is currently worth around $0.0.
The recent price movement of JNJ means that it is now down by -14.29% from its 52-week high and 5.54% up against its 52-week low prices. Over the past one week, the price volatility of JNJ stands at 2.21% while the volatility over the past one month is 1.70%. The beta score for this stock is 0.70. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company on 10/15/2019 published its latest quarterly earnings, with the report showing that the company recorded 1.97 earnings per share (EPS) during that period. This report was above the expectations of analysts of 1.95 by 0.02. The revenue by the firm was 20.79B for the quarter.
The shares of Johnson & Johnson (JNJ) dropped by -6.22%, leading to a loss of -$8.47 per share, and saw JNJ end the trading session at $127.70 on Friday 10/18/19. JNJ started the trading session at $133.31, before reaching a daily high of $134.3875. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $127.70.
The trading volume on Friday stood at 25511659, which was below the stock’s 3-month average volume of 7.41 million shares, out of a total 2.64B shares. As the price of the stock dipped, the market valuation of the company dropped to 359.37 billion.
The shares of Beyond Meat Inc. (NASDAQ: BYND) went down by -6.27% by the end of the recent trading session. This movement saw its price plunge to close at $109.99, which was lower than the previous closing price of $117.35. Over the past one week, the price of BYND has slipped by -16.29%, while it has recorded a loss of -29.00% over the past one month. Its three-month performance saw BYND lose -43.36%. The situation is different though over the year-to-date (YTD) price performance jumped by 67.29%. The stock price has gone up by +1.93% compared to its 90-day low, while it is down -54.12% compared to its 90-day high price.
Several brokerage firms sent out their reports BYND stock not long ago. In its report sent out on October 18, 2019, Bernstein lowered its ratings on BYND to a Mkt Perform. In an earlier report on October 17, 2019, BofA/Merrill Reiterated the stock to a Neutral. Wells Fargo meanwhile in its report on October 14, 2019 Initiated its rating of the stock to “Market Perform”.
In related news to the company’s stock, around 30.00% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 178 institutions currently hold the BYND stock. In the last quarter, a 5,743,672 BYND shares were in the possession of institutions. On the other hand, the company recorded 162 new institutions who bought it their stock, while 2 institutions sold their entire BYND reserve. Of the current institutions investing in the stock, 169 increased their investment while 4 decreased their investment in the stock.